Skip to main content

Anterior Cruciate Ligament Rupture

0
Pipeline Programs
4
Companies
4
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Providence Therapeutics
1 program
ACL repair without anterolateral repairN/A1 trial
Active Trials
NCT04373408Unknown120Est. Dec 2023
iNova Pharmaceuticals
iNova PharmaceuticalsAustralia - Chatswood
1 program
Blood Flow Restriction TherapyN/A1 trial
Active Trials
NCT03758755Completed49Est. Oct 2022
Arthrex
ArthrexCA - Santa Barbara
1 program
Fertilized ACLN/A1 trial
Active Trials
NCT06294314Recruiting450Est. Jul 2028
UNION therapeutics
UNION therapeuticsDenmark - Hellerup
1 program
The Clinical Outcome of Anterior Cruciate Ligament ReconstructionN/A1 trial
Active Trials
NCT03984474Unknown100Est. Dec 2021

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
ArthrexFertilized ACL
Providence TherapeuticsACL repair without anterolateral repair
iNova PharmaceuticalsBlood Flow Restriction Therapy
UNION therapeuticsThe Clinical Outcome of Anterior Cruciate Ligament Reconstruction

Clinical Trials (4)

Total enrollment: 719 patients across 4 trials

NCT06294314ArthrexFertilized ACL

Return to Play After ACL Reconstruction With Bone Marrow Aspirate, DBM, and an Internal Brace

Start: Feb 2024Est. completion: Jul 2028450 patients
N/ARecruiting
NCT04373408Providence TherapeuticsACL repair without anterolateral repair

ALL Ultrasound Predicts the Success of ACL Repair?

Start: Jul 2020Est. completion: Dec 2023120 patients
N/AUnknown
NCT03758755iNova PharmaceuticalsBlood Flow Restriction Therapy

Blood Flow Restriction Following ACL Reconstruction

Start: Nov 2018Est. completion: Oct 202249 patients
N/ACompleted
NCT03984474UNION therapeuticsThe Clinical Outcome of Anterior Cruciate Ligament Reconstruction

The Clinical Outcome of Anterior Cruciate Ligament Reconstruction

Start: Jan 2003Est. completion: Dec 2021100 patients
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 719 patients
4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.